Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
LIXIANA
BRANDED
Edoxaban is a highly selective, direct and reversible inhibitor of factor Xa, the serine protease located in the final common pathway of the coagulation cascade.
Available at :
Share this article
Related
Articles
Mesenchymal Stem Cells in Hemorrhagic Stroke: What Are the Outcomes?
by dr. Hastarita Lawrenti | 09 Jan 2026
Comparative Analysis of the Net Clinical Benefit of DOACs in Atrial Fibrillation (COMBAT-AF)
by dr. Theonardy Tjhia | 10 Dec 2025
Enteral Nutrition Benefits Stroke Patients
by dr. Dedyanto Henky Saputra, M.Gizi | 21 Nov 2025
Benefits of Citicoline in Patients with Mild Cognitive Impairment and Other Neurological Conditions
by dr. Hastarita Lawrenti | 20 Jan 2025
Recognize the Danger of Heatsroke to the Body
by dr. Vivian Keung | 07 May 2024
Strategies for Primary VTE Prophylaxis in Cancer Patients Undergoing Major Abdominal/Pelvic Surgery
by dr. Tjhia Theonardy Gilroy Yonathan | 02 May 2024
Heart Failure Incident Leads to Long-Term VTE Risk
by dr. Tjhia Theonardy Gilroy Yonathan | 02 Apr 2024
Vitamin D is Beneficial in Post-Stroke Patients
by dr. Esther Kristiningrum | 03 Oct 2023
Fondaparinux Safety Profile Better Than UFH as Post-PCI Anticoagulant
by dr. Lyon Clement | 12 Sep 2022
Fondaparinux as VTE Prophylaxis Post Lumbar Spine Surgery
by dr. Martinova Sari Panggabean | 19 May 2022
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE